Alembic Pharma announced that the company has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) Teriflunomide Tablets, 7 mg and 14 mg. The approved ANDA is therapeutically equivalent to the reference listed drug(RLD), Aubagio Tablets, 7 mg and 14 mg, of Sanofi- Aventis. Teriflunomide tablets are indicated for the treatment of patients with relapsing forms of multiple sclerosis.